Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
Clinical trial NCT00992784 · COMPLETED
Trial details
- NCT number
- NCT00992784
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-15
- Primary completion
- 2010-05-27
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.